Related Experiment Video
Updated: Feb 3, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
17.1K
Cognitive Frailty in Geriatrics.
Hidenori Arai1, Shosuke Satake2, Koichi Kozaki3
1National Center for Geriatrics and Gerontology, 7-430, Morioka-cho, Obu, Aichi 474-8511, Japan.
Clinics in Geriatric Medicine
|October 20, 2018
Summary
Cognitive frailty, defined in 2013, is uncommon in communities but prevalent in clinics. This condition increases risks for disability, poor quality of life, dementia, and mortality in older adults.
Area of Science:
- Gerontology
- Cognitive Science
- Public Health
Background:
- The concept of cognitive frailty was operationally defined in 2013.
- Numerous studies have since investigated its prevalence and associated health outcomes.
- Understanding cognitive frailty is crucial for geriatric care and public health strategies.
Purpose of the Study:
- To review the existing literature on the prevalence and outcomes of cognitive frailty.
- To highlight the implications of cognitive frailty for older adults' health and well-being.
- To discuss the potential effectiveness of interventions for cognitive frailty.
Main Methods:
- Systematic review of studies on cognitive frailty prevalence.
- Analysis of longitudinal data on cognitive frailty outcomes.
- Synthesis of findings regarding risk factors and interventions.
Main Results:
- Cognitive frailty prevalence is low in community settings but higher in clinical populations.
- Longitudinal studies indicate cognitive frailty is a significant risk factor for disability, reduced quality of life, dementia, and mortality.
- Multimodal interventions show promise in mitigating adverse outcomes.
Conclusions:
- Cognitive frailty, despite its low community prevalence, poses significant risks to older adults.
- Early identification and intervention are essential for improving health outcomes.
- Multimodal approaches are recommended for managing cognitive frailty and its associated risks.
Related Concept Videos
01:38Cognitive Dissonance
37.5K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
01:15Drug Dosing: Geriatric Patients
273
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
273
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
237
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
237
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
261
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
254
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
254